- 全部删除
您的购物车当前为空
GSK1379725A 是一种选择性 BPTF 配体,Kd 为 2.8 μM。


为众多的药物研发团队赋能,
让新药发现更简单!
GSK1379725A 是一种选择性 BPTF 配体,Kd 为 2.8 μM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 518 | In stock | |
| 5 mg | ¥ 1,180 | In stock | |
| 10 mg | ¥ 1,960 | In stock | |
| 25 mg | ¥ 3,290 | In stock | |
| 50 mg | ¥ 4,600 | In stock | |
| 100 mg | ¥ 5,920 | In stock | |
| 200 mg | ¥ 7,990 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,190 | In stock |
GSK1379725A 相关产品
| 产品描述 | GSK1379725A is a selective BPTF ligand (Kd = 2.8 μM). |
| 靶点活性 | BPTF:2.8 μM(Kd) |
| 体外活性 | Although GSK1379725A has been demonstrated to be selective over Brd4, a full selectivity panel against other bromodomains will be needed. A database search using ChEMBL only showed GSK1379725A to be active in five cellular assays (EC50: 500 nM) carried out. Additionally, no kinase activity has been reported for GSK1379725A despite the growing screening use of the PKIS library[1]. From the NMR titration of GSK1379725A, the bound and unbound resonances are separated by 171 Hz, providing an upper bound for the chemical exchange rate. Assuming an association rate of 1×108 M-1 s-1 as a high end for a range of protein-small molecule interactions, (e.g., chymotrypsin: proflavin k1=1.2×108 M-1 s-1), an upper Kd of 8 μM is estimated from this experiment. For a more accurate determination with a non-fluorinated protein, ITC is used as a complementary direct binding assay using unlabeled BPTF. A Kd of 2.8 μM is obtained, consistent with our intermediate exchange resonance broadening by PrOF NMR. |
| 分子量 | 450.47 |
| 分子式 | C23H23FN6O3 |
| CAS No. | 1802251-00-8 |
| Smiles | COC(=O)c1cccc(NC(=O)NC2CCN(C2)c2ccnc(Nc3ccc(F)cc3)n2)c1 |
| 密度 | 1.39 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (111 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容